Spots Global Cancer Trial Database for neoadjuvant immunochemotherapy
Every month we try and update this database with for neoadjuvant immunochemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma | NCT05964101 | Neoplasms Carcinoma, Squa... Antineoplastic ... | Nivolumab Injec... | 18 Years - 75 Years | The First Affiliated Hospital of Guangzhou Medical University | |
| Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC（neoSCORE） | NCT04459611 | Non-small Cell ... | sintilimab pemetrexed Carboplatin albumin-bound p... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Neoadjuvant Immunochemotherapy for LAOSCC | NCT06258811 | Oral Squamous C... Locally Advance... | albumin paclita... | 18 Years - 75 Years | Huashan Hospital | |
| Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC） | NCT06011993 | Head and Neck S... | 18 Years - 80 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||
| Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma | NCT05964101 | Neoplasms Carcinoma, Squa... Antineoplastic ... | Nivolumab Injec... | 18 Years - 75 Years | The First Affiliated Hospital of Guangzhou Medical University | |
| Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ） | NCT05429463 | Squamous Cell N... | Sintilimab Carboplatin Albumin-Bound P... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma | NCT05964101 | Neoplasms Carcinoma, Squa... Antineoplastic ... | Nivolumab Injec... | 18 Years - 75 Years | The First Affiliated Hospital of Guangzhou Medical University | |
| Neoadjuvant Immunochemotherapy for LAOSCC | NCT06258811 | Oral Squamous C... Locally Advance... | albumin paclita... | 18 Years - 75 Years | Huashan Hospital | |
| Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC | NCT05974007 | Non-Small Cell ... | Neoadjuvant imm... Neoadjuvant che... | 18 Years - 85 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ） | NCT05429463 | Squamous Cell N... | Sintilimab Carboplatin Albumin-Bound P... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC（neoSCORE） | NCT04459611 | Non-small Cell ... | sintilimab pemetrexed Carboplatin albumin-bound p... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Minimally Residual of Esophageal Cancer 001 | NCT05952661 | Esophageal Carc... Minimal Residua... | 18 Years - 75 Years | Hebei Medical University Fourth Hospital | ||
| Neoadjuvant Immunochemotherapy for Lung Cancer | NCT06023797 | Lung Cancer | Neoadjuvant imm... | 18 Years - | Shanghai Zhongshan Hospital | |
| Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma | NCT04280822 | Esophageal Canc... Surgery Neoadjuvant Tre... Survival | Neoadjuvant imm... | 18 Years - 75 Years | Henan Cancer Hospital | |
| Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma | NCT04280822 | Esophageal Canc... Surgery Neoadjuvant Tre... Survival | Neoadjuvant imm... | 18 Years - 75 Years | Henan Cancer Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
